Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/559
Name: Drug, bio-affecting and body treating compositions > Extract, body fluid, or cellular material of undetermined constitution derived from animal is active ingredient > Urogenital system (e.g., kidney, etc.) > Genitalia (e.g., ovary, uterus, prostate, testis, etc.)
Description: Subject matter in which the material is or is derived from the female or male genitalia, such as the ovary, uterus, prostate, and testis.

Patents under this class:

Patent Number Title Of Patent Date Issued
8691276 Extracellular matrix-derived gels and related methods Apr. 8, 2014
8361503 Extracellular matrix-derived gels and related methods Jan. 29, 2013
7671027 Use of GnRH agonists to support the luteal phase during infertility treatment Mar. 2, 2010
RE39337 Nude mouse model for human neoplastic disease Oct. 10, 2006
6916492 Natural nontoxic multicolor fluorescent protein dye from a marine invertebrate, compositions containing the said dye and its uses Jul. 12, 2005
6908627 Conditioned media for inhibiting growth of tumor cells Jun. 21, 2005
6689391 Natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses Feb. 10, 2004
6656969 Methods and compositions for inhibiting the proliferation of prostate cancer cells Dec. 2, 2003
6562621 Method of using fish ovarian fluid for culture and preservation of mammalian cells May. 13, 2003
6306823 Purified new epididymal forward motility protein and a process for isolation of the said epididymal forward motility protein useful as a fertility promoter/blocker Oct. 23, 2001
RE37224 Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant Jun. 12, 2001
6054142 Biocompatible devices with foam scaffolds Apr. 25, 2000
5997908 Prostate extract supplemented with zinc Dec. 7, 1999
5925362 Method to elicit an antitumor response with human prostate-specific antigen Jul. 20, 1999
5830460 Sertoli cells as transplantation facilitator for cell transplantation Nov. 3, 1998
5736141 Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant Apr. 7, 1998
5721348 DNA encoding PH-20 proteins Feb. 24, 1998
5708157 Secreted proteins and polynucleotides encoding them Jan. 13, 1998
5569812 Nude mouse model for human neoplastic disease Oct. 29, 1996
5563059 Use of human inhibin and human activin to increase the number of mature primate oocytes Oct. 8, 1996
5560935 Physiologically active substances extracted from activated tissues Oct. 1, 1996
5484768 Treatment of male infertility by administration of a muellerian inhibiting substance and surgery and/or hormonal treatment Jan. 16, 1996
5411748 Prostate extract supplemented with zinc May. 2, 1995
5277917 Ovarian cancer ascites factor, in isolated form Jan. 11, 1994
5198216 Performance enhancing compositions of matter, and methods of preparing and utilizing same Mar. 30, 1993
5102867 Therapeutic treatment of abnormal cell growth with follicle regulatory protein Apr. 7, 1992
5102868 Method for inhibiting follicular maturation Apr. 7, 1992
5057497 Oral method for the maintenance of healthy gingival tissues using TRF Oct. 15, 1991
5057324 Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof Oct. 15, 1991
5011687 Purified Mullerian inhibiting substance and process for treating human ovarian cancer cells Apr. 30, 1991
4996297 Recombinantly expressed rabbit zona pellucida polypeptides Feb. 26, 1991
4985254 Method of treating ischemic diseases Jan. 15, 1991
4962187 Common antigen for colorectal and mucinous ovarian tumors and process for isolating the same Oct. 9, 1990
4784960 Process for preparation of control for use in progesterone receptor Nov. 15, 1988
4749522 Supercritical fluid extraction of animal derived materials Jun. 7, 1988
4423151 Process for preparation of control for use in estrogen receptor tests Dec. 27, 1983
4314994 Process for obtaining a plasminogen activator Feb. 9, 1982
4083961 Plasminogen activator pharmaceutical compositions Apr. 11, 1978

  Recently Added Patents
Method for using a super-slippery thin layer characterized by the method for making same
Method of isolating human neuroepithelial precursor cells from human fetal tissue
Micro-fluidic device
Debugging using code analysis
System and method for the heterologous expression of polyketide synthase gene clusters
Solar powered charging shelter and system and method thereof
Simplified algorithm for abnormal situation prevention in load following applications including plugged line diagnostics in a dynamic process
  Randomly Featured Patents
Expediting electronic funds transfers
Method and apparatus for a selective optical retroreflector
Precharge circuitry for an electrically alterable non-volatile memory
Gift package
Polymeric contact lens material of improved oxygen permeability
Electrophotographic photoreceptor
Biocompatible polymer systems carrying triflusal or HTB
Method and apparatus for increasing acceptance and adjusting the rate of pressure variations within a prespecified range in precharged fluid storage systems
Methods of manufacturing temperature-stabilized storage containers
Customer self service subsystem for context cluster discovery and validation